Demonstration of basal cell immunofluorescence in drug-induced toxic epidermal necrolysis.
D000328:Adult; D001665:Binding Sites; D002746:Chlorpromazine / Q000009:adverse effects; D003165:Complement System Proteins / Q000032:analysis; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D007136:Immunoglobulins / Q000032:analysis; D007223:Infant; D008297:Male; D010406:Penicillins / Q000009:adverse effects; D012867:Skin / Q000276:immunology*; D013262:Stevens-Johnson Syndrome / Q000209:etiology / Q000276:immunology*
D007074:Immunoglobulin G; D007136:Immunoglobulins; D010406:Penicillins; D003165:Complement System Proteins; D002746:Chlorpromazine